Dignitana AB (DIGN.ST)

DIGN.ST on Stockholm Stock Exchange

7:04am EDT
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for DIGN.ST


Dignitana AB is a Sweden-based medical technology company. It develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The Company focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold... (more)
No analyst recommendations are available for DIGN.ST.


Beta: 0.39
Market Cap(Mil.): kr187.71
Shares Outstanding(Mil.): 14.27
Dividend: --
Yield (%): --


  DIGN.ST Industry Sector
P/E (TTM): -- 41.62 40.89
EPS (TTM): -0.93 -- --
ROI: -46.55 10.90 16.14
ROE: -46.55 12.65 16.96
Search Stocks

BRIEF-FDA converts Dignitana PMA application to a de novo regulatory 510(k)

* Says sent in two separate letters to the Food and Drug Administration (FDA), one to pull back application for Premarket Approval and one to request a conversion to de novo regulatory 510k)

24 Mar 2015

BRIEF-Dignitana Q4 pre-tax loss narrows to SEK 1.1 million

* Q4 net sales 9 million Swedish crowns ($1.10 million) versus 4.2 million crowns year ago

24 Feb 2015

BRIEF-Dignitana rights issue oversubscribed

* Receives proceeds of about 16.9 million Swedish crowns ($2.05 million) before issue costs Source text for Eikon: Further company coverage: ($1 = 8.2589 Swedish crowns) (Gdynia Newsroom)

02 Feb 2015

BRIEF-Dignitana carries out preferential rights issue of SEK 16.9 million

* Carries out a preferential rights issue of 16.9 million Swedish crowns

25 Nov 2014

BRIEF-Dignitana Q3 revenue up to SEK 3.4 million

* Q3 revenue 3.4 million Swedish crowns versus 812,000 crowns

25 Nov 2014

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime
Provider: GlobalData
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks